Framework agreements for antineoplastic and antihemorrhagic medicines

Summary

The procurement concerns framework agreements for the supply of antineoplastic (cancer drugs) and antihemorrhagic medicines to be delivered under multiple lots over a 24-month period. The framework sets out the expected volumes and maximum framework amounts per lot (in Romanian Leu). The award criterion is the lowest price, with the ranking determined by total price across offers. Bidders must provide the required qualification and compliance evidence, including DUAE documents and market authorization where applicable, and comply with electronic submission procedures and contract performance requirements.